Strontium ranelate

A strontium(II) salt of ranelic acid that stimulates CaSR and leads to the differentiation of pre-osteoblast to osteoblast, increases the bone formation; also stimulates osteoblasts to secrete osteoprotegerin in inhibiting osteoclasts formed from pre-osteoclasts in relation to the RANKL system; a medication for osteoporosis treatment.OsteoporosisApproved

Target : CaSR

CAS Number : 135459-87-9

Formula Weight : 513.4896

Molecular Formula : C12H6N2O8SSr2

Purity : >98% (HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.